Kristian Humer insider trades

Open-market stock purchases and sales by Kristian Humer, Chief Financial Officer at 4D Molecular Therapeutics, Inc, from SEC Form 4 filings since Jul 26, 2021.

Recent trades

DateStockTradeValue
Dec 9, 2025FDMT 4D Molecular Therapeutics, IncBought (not open market)—

Companies traded

  • FDMT 4D Molecular Therapeutics, Inc: other filings, last Dec 9, 2025
  • SNSE Sensei Biotherapeutics, Inc: other filings, last May 21, 2025
  • FHTX Foghorn Therapeutics Inc: other filings, last Jan 22, 2025
  • VRDN Viridian Therapeutics, Inc.\DE: other filings, last Feb 8, 2023

Get free alerts when Kristian Humer files a new trade →